Corticotropin releasing factor: Began two Phase I/II trials

Neurobiological Technologles Inc. (NTII), Richmond, Calif. Product: Corticotropin releasing factor (CRF) Indication: Inflammation in brain tumors and rheumatoid arthritis Status: Began two Phase I/II ...